DMD and Becker muscular dystrophy: The differences in disease progression between DMD and BMD form the basis of potential therapeutic interventions using antisense oligomers (AOs) that aim to induce exon skipping and generate a BMD-like dystrophin isoform from a DMD-mutated dystrophin gene [8,9,10].